PT-141 Reconstitution Chart (Every Vial Size)

Overview of PT-141 and Reconstitution Science

PT-141, chemically known as Bremelanotide, is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH). In preclinical literature, PT-141 is classified primarily as a central melanocortin agonist, exhibiting potent affinity for the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptor subtypes within the central nervous system. Unlike traditional vasoactive agents, research indicates that PT-141 operates via neuroendocrine signaling pathways to modulate central control mechanisms associated with sexual-health pathways, behavioral responses, and vascular tone in animal models.

To evaluate PT-141 in laboratory settings, researchers must reconstitute the lyophilized powder into a liquid solution suitable for precise micro-pipetting, cell culture assays, or animal model administration. Reconstitution requires strict adherence to mathematical ratios to ensure target concentrations (measured in milligrams per milliliter, or mg/mL) are met consistently. Laboratory personnel can source standardized lyophilized units such as PT-141 10mg vials across our full catalog of all peptides for experimental applications.

PT-141 Reconstitution Formula & Mathematical Derivation

Calculating the final concentration of a reconstituted peptide solution requires a basic volumetric formula: Concentration (mg/mL) = Total Peptide Mass (mg) / Volume of Diluent Added (mL). To determine the precise mass of peptide contained within a given withdrawal volume (e.g., a 0.1 mL aliquot), multiply the total concentration by the aliquot volume: Aliquot Mass (mg) = Concentration (mg/mL) × Aliquot Volume (mL).

Consider two standard laboratory calculations using this mathematical model:

**Worked Example 1:** A researcher reconstitutes a 10 mg vial of lyophilized PT-141 with 2.0 mL of Bacteriostatic Water. Utilizing the primary formula: Concentration = 10 mg / 2.0 mL = 5.0 mg/mL. If an assay protocol calls for a 0.1 mL volumetric draw, the delivered peptide mass equals: 5.0 mg/mL × 0.1 mL = 0.5 mg (or 500 mcg).

**Worked Example 2:** A lab technician reconstitutes a 5 mg vial of lyophilized PT-141 with 2.5 mL of sterile diluent. Applying the formula: Concentration = 5 mg / 2.5 mL = 2.0 mg/mL. A 0.1 mL aliquot drawn from this vial delivers: 2.0 mg/mL × 0.1 mL = 0.2 mg (or 200 mcg).

Master PT-141 Reconstitution Reference Chart

The following reference table outlines resulting peptide concentrations across standard lyophilized vial masses (10 mg, 5 mg, and 2 mg) when mixed with common laboratory diluent volumes (1.0 mL to 5.0 mL). These values allow researchers to rapidly select diluent volumes that match their target aliquot concentrations.

| Vial Mass (mg) | Diluent Added (mL) | Final Concentration (mg/mL) | Mass per 0.1 mL Aliquot | Mass per 0.05 mL Aliquot | |---|---|---|---|---| | 10 mg | 1.0 mL | 10.0 mg/mL | 1.0 mg (1000 mcg) | 0.5 mg (500 mcg) | | 10 mg | 2.0 mL | 5.0 mg/mL | 0.5 mg (500 mcg) | 0.25 mg (250 mcg) | | 10 mg | 2.5 mL | 4.0 mg/mL | 0.4 mg (400 mcg) | 0.2 mg (200 mcg) | | 10 mg | 5.0 mL | 2.0 mg/mL | 0.2 mg (200 mcg) | 0.1 mg (100 mcg) | | 5 mg | 1.0 mL | 5.0 mg/mL | 0.5 mg (500 mcg) | 0.25 mg (250 mcg) | | 5 mg | 2.0 mL | 2.5 mg/mL | 0.25 mg (250 mcg) | 0.125 mg (125 mcg) | | 5 mg | 2.5 mL | 2.0 mg/mL | 0.2 mg (200 mcg) | 0.1 mg (100 mcg) | | 5 mg | 5.0 mL | 1.0 mg/mL | 0.1 mg (100 mcg) | 0.05 mg (50 mcg) | | 2 mg | 1.0 mL | 2.0 mg/mL | 0.2 mg (200 mcg) | 0.1 mg (100 mcg) | | 2 mg | 2.0 mL | 1.0 mg/mL | 0.1 mg (100 mcg) | 0.05 mg (50 mcg) |

For custom vial sizes or unconventional diluent volumes, laboratory personnel should utilize our interactive reconstitution calculator to eliminate manual calculation errors prior to reagent prep.

Step-by-Step Laboratory Reconstitution Protocol

Reconstituting lyophilized peptides requires strict aseptic technique to avoid biological contamination and preserve structural integrity. Lab personnel should perform all steps inside a certified laminar flow hood or clean bench setup.

1. **Preparation:** Clean the laboratory workspace with 70% isopropyl alcohol. Allow the lyophilized PT-141 vial and diluent to equilibrate to room temperature (20°C–25°C) for 15 minutes prior to reconstitution to reduce thermal shock to the peptide matrix. 2. **Sanitization:** Remove the plastic flip-off cap from the PT-141 vial. Swab the exposed rubber stopper with a sterile alcohol wipe and allow it to air-dry completely. 3. **Diluent Withdrawal:** Using a sterile syringe equipped with an appropriate gauge needle (e.g., 21G to 25G), draw the exact volume of diluent (e.g., Bacteriostatic Water) indicated by your experimental protocol. 4. **Reagent Transfer:** Insert the needle through the center of the rubber stopper at a 45-degree angle. Direct the diluent stream against the glass side wall of the vial rather than shooting it directly onto the lyophilized cake. Allow the internal vacuum of the vial to draw the liquid naturally. 5. **Dissolution:** Slowly withdraw the syringe. Gently swirl the vial in a smooth circular motion until the lyophilized cake is fully dissolved. **Do not shake or vortex** the vial, as mechanical agitation can induce shear stress, causing peptide denaturation or aggregation.

Selecting Diluents: Bacteriostatic Water vs. Sterile 0.9% NaCl

The choice of reconstitution solvent depends directly on the intended timeline and design of the research project. The two primary diluents used for laboratory peptide reconstitution are Bacteriostatic Water (0.9% Benzyl Alcohol) and Normal Saline (0.9% Sodium Chloride).

Bacteriostatic Water is the standard choice for multi-use research vials. The addition of 0.9% benzyl alcohol acts as a bacteriostatic preservative, inhibiting microbial growth and extending reconstituted stability for up to 28 days when maintained under strict refrigeration (2°C–8°C). Conversely, Sterile Water for Injection (without preservatives) or Normal Saline should be used when benzyl alcohol might interfere with sensitive cell culture assays or specific animal tissue models. However, unpreserved solutions must be used immediately or aliquoted and frozen to prevent degradation.

Comparative Analysis: Melanocortin Receptor Agonists in Preclinical Models

When designing preclinical assays targeting the melanocortin system, researchers frequently compare PT-141 to other synthetic structural analogs within the same functional family. While PT-141 functions as a selective central MC3R/MC4R agonist with minimal activity at peripheral skin receptors, related compounds like Melanotan II exhibit non-selective binding across MC1R, MC3R, MC4R, and MC5R. This broad binding profile of MT-II often induces robust melanogenesis in addition to central nervous system pathways.

Similarly, endogenous peptide fragments and broader melanocortin agonists demonstrate significantly shorter plasma half-lives due to rapid enzymatic cleavage by serum endopeptidases. The internal structural cyclization of PT-141 confers superior enzymatic resistance, making it ideal for extended preclinical signaling studies. Researchers evaluating comparative receptor kinetics can examine published analytical data across our research hub to select the correct candidate for their experimental models.

Storage, Shelf Life, and Stability Guidelines

Proper storage conditions are critical for preserving the bioactivity and purity of PT-141 reagents. Lyophilized peptide powder remains stable at room temperature for short periods during shipping, but long-term storage requires temperature-controlled environments.

Unreconstituted (lyophilized) PT-141 should be stored in a freezer at -20°C for up to 24 months, or at -80°C for extended archival storage. Protect lyophilized vials from direct light exposure. Once reconstituted with Bacteriostatic Water, store the liquid solution in a lab refrigerator at 2°C to 8°C. Avoid subject freezing and thawing cycles of reconstituted liquid, as phase changes degrade the peptide chain. If long-term liquid storage is necessary, aliquot the reconstituted solution into sterile, single-use microcentrifuge tubes and freeze immediately at -80°C.

Analytical Quality Standards and Purity Verification

Reproducibility in scientific research demands high-purity chemical reagents free from synthetic impurities, residual solvents, or bacterial endotoxins. PX1 Research subjects every batch of PT-141 to rigorous analytical testing in ISO 17025 accredited facilities in the USA.

Purity is verified via High-Performance Liquid Chromatography (HPLC) to guarantee continuous peptide purity exceeding 99%. Mass Spectrometry (MS) is conducted concurrently to confirm correct molecular weight and sequence identity. Furthermore, every lot undergoes chromogenic LAL endotoxin testing to confirm levels remain below strict threshold limits (<0.01 EU/mg). Lab directors can inspect batch-specific documentation by downloading our official Certificate of Analysis (COA). Institutional buyers requiring multi-gram quantities for large-scale research projects can access customized supply chains via our wholesale lab account portal.